Report Detail

Request for Sample of this report

Global Autoimmune Disease Market Size study, by Disease Type (Localized, Systemic), by Diagnostic (IFA, ELISA, Dot blot, Line Blot, Agglutination, Double Immune Diffusion, Western Blotting, Multiplex Immunoassay, Others), by Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment) and Regional Forecasts 2018-2025

RnM2739586
08 January, 2019
Global
200 Pages
Bizwit Research & Consulting LLP
Other

Global Autoimmune Disease Market to reach USD XX billion by 2025.

Global Autoimmune Disease Market valued approximately USD 37.81 billion in 2017 is anticipated to grow with a healthy growth rate of more than 3.82% over the forecast period 2018-2025. The Autoimmune Disease Market is continuously growing in global scenario over the coming years. The major driving factor of global Autoimmune Disease market is increasing incidence of chronic diseases and development of novel biomarkers such as Enbrel & Humira. In addition, improvement in regulatory framework, technological enhancements, and growing government assistance are also some other major factors which propelling the growth of the market. However, High treatment cost, poorly trained physicians and emergence of alternative technologies are some major factors which limiting the market growth. Autoimmune disease is a condition in which immune system mistakenly attacks body. These diseases cause dissimilarities in organ functioning, anomalous growth of organs and destruction of vigorous body. These disease are habitually chronic in nature and there is no remedial therapy. The common autoimmune diseases are Type 1 diabetes, Rheumatoid arthritis, Psoriasis/Psoriatic arthritis, Multiple sclerosis, Systemic lupus erythematous (lupus), Inflammatory bowel diseases, Myasthenia gravis, Vasculitis, Celiac disease and so on. Various types of treatment for theses diseases include physical therapy, blood transfusion, recombinant technology, chemo therapy, topical therapy, TNF-a antagonists and Helminthic.
The regional analysis of Global Autoimmune Disease Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing investment in R&D and increasing awareness among people related to healthcare. Europe is also estimating to project a major growth in the global Autoimmune Disease market due to increasing disposable income of individuals in the region. Asia-Pacific is also anticipated to exhibit higher growth rate/CAGR over the forecast period 2018-2025 due to improving health infrastructure and increasing aging population.
The major market player included in this report are:
• Abbott Laboratories
• Active Biotech
• Eli Lilly
• Bristol-Myers Squibb
• AstraZeneca plc
• Pfizer
• Biogen Idec
• Lupin Limited
• GlaxoSmithKline
• Amgen
• 4SC
• F. Hoffmann-La Roche Ltd.
• AutoImmune Inc.
• Johnson & Johnson
• Bayer

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

 Localized
 Systemic

By Diagnostic:

 IFA
 ELISA
 Dot blot
 Line Blot
 Agglutination
 Double Immune Diffusion
 Western Blotting
 Multiplex Immunoassay
 Others

By Product:

 Drugs
 Therapeutic & Monitoring Equipment
 Diagnostic Equipment

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Autoimmune Disease Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
- 1.3.1. Autoimmune Disease Market, by Disease Type, 2015-2025 (USD Billion)
- 1.3.2. Autoimmune Disease Market, by Diagnostics, 2015-2025 (USD Billion)
- 1.3.3. Autoimmune Disease Market, by Products, 2015-2025 (USD Billion)
- 1.3.4. Autoimmune Disease Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Autoimmune Disease Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Autoimmune Disease Market Dynamics

3.1. See Saw Analysis
- 3.1.1. Market Drivers
- 3.1.2. Market Challenges
- 3.1.3. Market Opportunities

Chapter 4. Autoimmune Disease Market Industry Analysis

4.1. Porter’s 5 Force Model
- 4.1.1. Bargaining Power of Buyers
- 4.1.2. Bargaining Power of Suppliers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
- 4.2.1. Political Scenario
- 4.2.2. Economic Scenario
- 4.2.3. Social Scenario
- 4.2.4. Technological Scenario
4.3. Value Chain Analysis
- 4.3.1. Supplier
- 4.3.2. Manufacturers/Service Provider
- 4.3.3. Distributors
- 4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
- 4.6.1. Raw Material Cost Analysis
- 4.6.2. Manufacturing Cost Analysis
- 4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion

Chapter 5. Autoimmune Disease Market, by Disease Type

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Autoimmune Disease Market, Sub Segment Analysis
- 5.4.1. Localized
  - 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
  - 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
- 5.4.2. Systemic
  - 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
  - 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Autoimmune Disease Market, by Diagnostics
- 6.1. Market Snapshot
- 6.2. Market Performance - Potential Model
- 6.3. Key Market Players
- 6.4. Autoimmune Disease Market, Sub Segment Analysis
  - 6.4.1. IFA
    - 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.2. ELISA
    - 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.3. Dot blot
    - 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.4. Line blot
    - 6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.5. Agglutination
    - 6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.6. Double Immune Diffusion
    - 6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.7. Western Blotting
    - 6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.8. Multiplex Immunoassay
    - 6.4.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  - 6.4.9. Others
    - 6.4.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    - 6.4.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  Chapter 7. Autoimmune Disease Market, by Product
  - 7.1. Market Snapshot
  - 7.2. Market Performance - Potential Model
  - 7.3. Key Market Players
  - 7.4. Autoimmune Disease Market, Sub Segment Analysis
    - 7.4.1. Drugs
      - 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      - 7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    - 7.4.2. Therapeutic & Monitoring Equipment
      - 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      - 7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    - 7.4.3. Diagnostic Equipment
      - 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      - 7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    Chapter 8. Autoimmune Disease Market, by Regional Analysis
    - 8.1. Autoimmune Disease Market, Regional Market Snapshot (2015-2025)
    - 8.2. North America Autoimmune Disease Market Snapshot
      - 8.2.1. U.S.
        8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.2.2. Canada
        8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    - 8.3. Europe Autoimmune Disease Market Snapshot
      - 8.3.1. U.K.
        8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.3.2. Germany
        8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.3.3. France
        8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.3.4. Rest of Europe
        8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    - 8.4. Asia Autoimmune Disease Market Snapshot
      - 8.4.1. China
        8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.4.2. India
        8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.4.3. Japan
        8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.4.4. Rest of Asia Pacific
        8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    - 8.5. Latin America Autoimmune Disease Market Snapshot
      - 8.5.1. Brazil
        8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.5.2. Mexico
        8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    - 8.6. Rest of The World
      - 8.6.1. South America
        8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      - 8.6.2. Middle East and Africa
        8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        8.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
        8.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
      Chapter 9. Competitive Intelligence
      - 9.1. Company Market Share (Subject to Data Availability)
      - 9.2. Top Market Strategies
      - 9.3. Company Profiles
        9.3.1. Abbott Laboratories
        9.3.1.1. Overview
        9.3.1.2. Financial (Subject to Data Availability)
        9.3.1.3. Product Summary
        9.3.1.4. Recent Developments
        9.3.2. Active Biotech
        9.3.3. Eli Lilly
        9.3.4. Bristol-Myers Squibb
        9.3.5. AstraZeneca plc
        9.3.6. Pfizer
        9.3.7. Biogen Idec
        9.3.8. Lupin Limited
        9.3.9. GlaxoSmithKline
        9.3.10. Amgen
        9.3.11. 4SC
        9.3.12. F. Hoffmann-La Roche Ltd.
        9.3.13. AutoImmune Inc.
        9.3.14. Johnson & Johnson
        9.3.15. Bayer
      Chapter 10. Research Process
      - 10.1. Research Process
        10.1.1. Data Mining
        10.1.2. Analysis
        10.1.3. Market Estimation
        10.1.4. Validation
        10.1.5. Publishing

Automotive Airless Tire Market Report

Smart Door Locks Market Report

Summary:
Get latest Market Research Reports on Autoimmune Disease . Industry analysis & Market Report on Autoimmune Disease is a syndicated market report, published as Global Autoimmune Disease Market Size study, by Disease Type (Localized, Systemic), by Diagnostic (IFA, ELISA, Dot blot, Line Blot, Agglutination, Double Immune Diffusion, Western Blotting, Multiplex Immunoassay, Others), by Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment) and Regional Forecasts 2018-2025. It is complete Research Study and Industry Analysis of Autoimmune Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 08 January, 2019

1-User License	$3,950.00
Enterprise License	$5,550.00

1-User License	3,148.15
Enterprise License	4,423.35

1-User License	3,685.35
Enterprise License	5,178.15

1-User License	617,227.00
Enterprise License	867,243.00

1-User License	329,706.50
Enterprise License	463,258.50

Report Detail

Request for Sample of this report

Request for Sample of this report

Table Of Content

TABLE OF CONTENTS

Chapter 1. Executive Summary

Chapter 2. Autoimmune Disease Market Definition and Scope

Chapter 3. Autoimmune Disease Market Dynamics

Chapter 4. Autoimmune Disease Market Industry Analysis

Chapter 5. Autoimmune Disease Market, by Disease Type

Chapter 6. Autoimmune Disease Market, by Diagnostics

Chapter 7. Autoimmune Disease Market, by Product

Chapter 8. Autoimmune Disease Market, by Regional Analysis

Chapter 9. Competitive Intelligence

Chapter 10. Research Process

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter